GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Ms C Thomas
b)
Position/status
Senior Vice President, Human Resources
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
GlaxoSmithKline plc
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
Nature of the transaction
The exercise of options over 20,180 Ordinary Shares, granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan.
Price(s) and
volume(s)
Price(s)
Volume(s)
£11.47
20,180
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2016-07-28
f)
Place of the transaction
n/a
Sale of 17,024 Ordinary Shares to satisfy option costs and the tax and NI liability arising following the exercise of options over 20,180 Ordinary Shares granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan.
£17.0778
17,024
London Stock Exchange (XLON)
The exercise of options over 20,180 Ordinary Shares, granted on 20 February 2007 under the GlaxoSmithKline Share Option Plan.
£14.88
Sale of 19,235 Ordinary Shares to satisfy option costs and the tax and NI liability arising following the exercise of options over 20,180 Ordinary Shares granted on 20 February 2007 under the GlaxoSmithKline Share Option Plan.
£17.0814
19,235